Golimumab for the treatment of Hidradenitis Suppurativa

Published: 28-05-2021| Version 1 | DOI: 10.17632/fwjvy294wy.1
Contributor:
Christopher Sayed

Description

Golimumab for the Treatment of Hidradenitis Suppurativa

Files

Steps to reproduce

Subjects were identified with clinical tracking lists. Clinical data was pulled via chart review including lesion counts, demographics, disease severity, treatment duration and other clinical measures